CRIS Current Research Information System

MARASCO, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 12.662
NA - Nord America 11.381
EU - Europa 9.036
AF - Africa 839
SA - Sud America 700
OC - Oceania 34
Continente sconosciuto - Info sul continente non disponibili 1
Totale 34.653
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.111
IT - Italia 4.185
SG - Singapore 3.424
VN - Vietnam 3.292
CN - Cina 2.930
GB - Regno Unito 927
DE - Germania 872
HK - Hong Kong 819
SE - Svezia 663
IN - India 602
BR - Brasile 498
NL - Olanda 425
FR - Francia 391
BD - Bangladesh 368
KR - Corea 365
IE - Irlanda 281
RU - Federazione Russa 273
FI - Finlandia 271
CI - Costa d'Avorio 216
JP - Giappone 213
ZA - Sudafrica 171
CA - Canada 144
CH - Svizzera 123
SC - Seychelles 123
TG - Togo 112
PH - Filippine 85
ID - Indonesia 83
ES - Italia 76
BG - Bulgaria 74
UA - Ucraina 73
TH - Thailandia 71
TR - Turchia 69
AR - Argentina 68
NG - Nigeria 68
MX - Messico 67
JO - Giordania 65
AT - Austria 58
PL - Polonia 58
TW - Taiwan 56
BE - Belgio 50
PK - Pakistan 47
EE - Estonia 41
EC - Ecuador 34
IQ - Iraq 33
CL - Cile 31
EG - Egitto 29
LT - Lituania 29
AU - Australia 27
CD - Congo 27
GR - Grecia 24
TN - Tunisia 23
HR - Croazia 22
MA - Marocco 22
SA - Arabia Saudita 22
CO - Colombia 21
MY - Malesia 19
PT - Portogallo 19
RO - Romania 17
UZ - Uzbekistan 15
VE - Venezuela 15
KE - Kenya 14
PY - Paraguay 13
CZ - Repubblica Ceca 12
AE - Emirati Arabi Uniti 10
AL - Albania 10
HN - Honduras 10
HU - Ungheria 10
ET - Etiopia 9
IR - Iran 9
JM - Giamaica 9
NP - Nepal 9
CR - Costa Rica 8
KG - Kirghizistan 8
BO - Bolivia 7
RS - Serbia 7
BA - Bosnia-Erzegovina 6
DK - Danimarca 6
PE - Perù 6
TT - Trinidad e Tobago 6
AZ - Azerbaigian 5
KZ - Kazakistan 5
LV - Lettonia 5
OM - Oman 5
SN - Senegal 5
UY - Uruguay 5
BB - Barbados 4
BY - Bielorussia 4
DZ - Algeria 4
GT - Guatemala 4
LB - Libano 4
MD - Moldavia 4
MK - Macedonia 4
MT - Malta 4
NZ - Nuova Zelanda 4
SK - Slovacchia (Repubblica Slovacca) 4
AO - Angola 3
DO - Repubblica Dominicana 3
GH - Ghana 3
LA - Repubblica Popolare Democratica del Laos 3
NI - Nicaragua 3
Totale 34.591
Salva come PNG Salva come JPEG
Città #
Singapore 2.446
Ashburn 1.322
Fairfield 1.011
Ho Chi Minh City 853
Hong Kong 748
San Jose 737
Hanoi 731
Hefei 712
Southend 709
Bologna 686
Chandler 681
Milan 442
Santa Clara 405
Beijing 376
Rome 334
Seoul 317
Seattle 310
New York 305
Boardman 303
Houston 303
Woodbridge 291
Council Bluffs 289
Dublin 279
Los Angeles 269
Princeton 258
Wilmington 251
Dallas 243
Cambridge 238
Abidjan 216
Helsinki 174
Tokyo 174
Lauterbourg 166
Ann Arbor 165
Dong Ket 158
Florence 145
Da Nang 139
Frankfurt am Main 133
Haiphong 119
Lomé 112
Buffalo 105
Munich 105
Turin 105
Naples 104
Johannesburg 103
São Paulo 98
Redondo Beach 88
Brescia 83
Bern 79
Bengaluru 74
Sofia 72
Orem 71
Shanghai 71
Berlin 70
Des Moines 70
Abeokuta 64
Hyderabad 64
Amman 63
Las Vegas 62
Redmond 62
Chicago 61
Nanjing 59
San Diego 57
Bremen 55
Guangzhou 55
Westminster 52
Palermo 51
London 50
Padova 49
Montreal 48
Lappeenranta 47
Amsterdam 46
Parma 43
Falkenstein 42
Jakarta 41
Brooklyn 40
Rimini 40
San Francisco 40
Turku 40
Brussels 39
Hải Dương 39
North Charleston 39
Phoenix 39
Redwood City 38
Jinan 37
Toronto 37
Biên Hòa 36
Denver 36
Tianjin 36
Bến Tre 35
Changsha 34
Medford 34
Nuremberg 34
Atlanta 32
Warsaw 32
Modena 31
Chennai 30
Paris 30
Washington 30
Bari 29
The Dalles 29
Totale 20.835
Salva come PNG Salva come JPEG
Nome #
Italian guidelines for the management of irritable bowel syndrome: Joint Consensus from the Italian Societies of: Gastroenterology and Endoscopy (SIGE), Neurogastroenterology and Motility (SINGEM), Hospital Gastroenterologists and Endoscopists (AIGO), Digestive Endoscopy (SIED), General Medicine (SIMG), Gastroenterology, Hepatology and Pediatric Nutrition (SIGENP) and Pediatrics (SIP) 1.601
Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study 359
Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis 333
Management of Irritable Bowel Syndrome With Diarrhea 316
Monofocal hepatocellular carcinoma: How much does size matter? 295
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 288
Differences in liver stiffness values obtained with new ultrasound elastography machines and Fibroscan: A comparative study 287
Prognostic role of nutritional status in elderly patients hospitalized for COVID-19: a monocentric study 279
Collinsella aerofaciens as a predictive marker of response to probiotic treatment in non-constipated irritable bowel syndrome 277
Ablation for hepatocellular carcinoma: beyond the standard indications 269
Imaging-based diagnosis of benign lesions and pseudolesions in the cirrhotic liver 264
A combined Baveno VII and spleen stiffness algorithm to improve the non-invasive diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease 260
How to clarify the Baveno VI criteria for ruling out varices needing treatment by noninvasive tests 259
Beneficial prognostic effects of aspirin in patients receiving sorafenib for hepatocellular carcinoma: A tale of multiple confounders 257
Pattern of macrovascular invasion in hepatocellular carcinoma 242
A nomogram-based prognostic model for advanced hepatocellular carcinoma patients treated with sorafenib: A multicenter study 241
Lactiplantibacillus plantarum (CECT7484 and CECT7485) and Pedioccoccus acidilactici (CECT7483) enhance actin cytoskeleton and CYP1A1 expression restoring epithelial permeability alterations induced by irritable bowel syndrome mediators 240
Geraniol Treatment for Irritable Bowel Syndrome: A Double-Blind Randomized Clinical Trial 240
Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma 235
Sarcopenia predicts ascitic decompensation and mortality independently of portal hypertension status in patients with advanced chronic liver disease outside the liver transplantation setting 233
Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia 232
Factors That Affect Adequacy of Colon Cleansing for Colonoscopy in Hospitalized Patients 229
Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study 226
The duration of the conventional chemoembolization for hepatocellular carcinoma: factors affecting the procedural time 223
Sarcopenia evaluated by EASL/AASLD computed tomography-based criteria predicts mortality in patients with cirrhosis: A systematic review and meta-analysis 221
DAAs treatment in HCV recurrence after liver transplantation: Clinical usefulness of non-invasive methods 221
Clinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatments 221
Complete Remission of Advanced Hepatocellular Carcinoma Treated with Sorafenib and Concomitant Appearance of IgG4- related Diseases. A Case Report 219
Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals 217
Inflammatory and Microbiota-Related Regulation of the Intestinal Epithelial Barrier 215
Size and location of spontaneous portosystemic shunts predict the risk of decompensation in cirrhotic patients 213
Adverse Food Reaction and Functional Gastrointestinal Disorders: Role of the Dietetic Approach 211
Clinical impact of sarcopenia assessment in patients with liver cirrhosis 211
The changing scenario of hepatocellular carcinoma in Italy: an update 209
Pancreatic ultrasound elastography and its clinical use in predicting the risk of pancreatic fistulas after pancreatic resection 208
Gut microbiota, metabolome and immune signatures in patients with uncomplicated diverticular disease 206
Eosinophilic colitis: A clinical review 200
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 200
Molecular Mechanisms Underlying Loss of Vascular and Epithelial Integrity in Irritable Bowel Syndrome 198
Gut Microbiota and Celiac Disease 194
Corrigendum to “Differences in liver stiffness values obtained with new ultrasound elastography machines and fibroscan: A comparative study” [Dig. Liver Dis. 49 (2017) 802–808](S1590865817302463)(10.1016/j.dld.2017.03.001) 194
Pathophysiology of Diverticular Disease: From Diverticula Formation to Symptom Generation 192
A SPLEEN STIFFNESS MEASUREMENT-BASED MODEL FOR THE RECOGNITION OF HIGH RISK VARICES: BAVENO VI CRITERIA AND BEYOND 191
Clinical Role of Lung Ultrasound for the Diagnosis and Prognosis of Coronavirus Disease Pneumonia in Elderly Patients: A Pivotal Study 190
Non-celiac gluten sensitivity in the context of functional gastrointestinal disorders 190
DAAs treatment in hepatitis C virus recurrence after Liver Transplantation: clinical usefulness of non-invasive methods 189
“Are the Expanded Baveno VI Criteria really safe to screen compensated cirrhotic patients for high-risk varices?” 188
Guidance for Fecal Microbiota Transplantation Trials in Ulcerative Colitis: The Second ROME Consensus Conference 187
A New Quantitative Classification of the Extrahepatic Biliary Tract Related to Cystic Duct Implantation 187
The non‐invasive evaluation of liver involvement in patients with cystic fibrosis: A prospective study 185
Advances in Endo-Hepatology: The Role of Endoscopic Ultrasound in the Management of Portal Hypertension 185
Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: Predictive role in HCC development in cirrhotic patients 184
Probiotics, Prebiotics and Other Dietary Supplements for Gut Microbiota Modulation in Celiac Disease Patients 184
Post COVID-19 irritable bowel syndrome 181
Are noninvasive methods clinically useful in advanced, decompensated liver cirrhosis when "les Jeux Sont Faits"? 181
The Effect of Supplementing a Novel n-3 Polyunsaturated Fatty Acids Formulation Containing Schisandra chinensis Extract and Vitamin D3 to a Group of Elite Sport Athletes on Competition Related Stress, Anxiety and Self-confidence 180
Spleen stiffness measurement: A useful prognostic tool in HCV patients treated with DAAs regimens 179
Liver collision lesion: inflammatory hepatocellular adenoma within focal nodular hyperplasia 179
null 179
Concomitant Heterotopic Pancreas and Endometriosis as a Rare Cause of Ileo-Ileal Intussusception in a Young Woman with Spina Bifida: Case Report and Literature Review 178
A spleen stiffness measurement-based model for the recognition of high risk varices: Baveno VI criteria and beyond 176
Spleen stiffness decrease as mirror of portal hypertension changes after successful interferon-free therapy in chronic-HCV patients 175
THU-492 - Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: predictive role in hepatocellular carcinoma development in in cirrhotic patients 174
Usefulness of liver stiffness measurement in predicting hepatic veno-occlusive disease development in patients who undergo HSCT 172
Standardization of conventional chemoembolization for hepatocellular carcinoma 172
Overview of prognostic systems for hepatocellular carcinoma and ITA.LI.CA external validation of MESH and CNLC classifications 172
Association between anatomic variations of extrahepatic and intrahepatic bile ducts: Do look up! 171
Diagnostic imaging for acute abdominal pain in an Emergency Department in Italy 171
THU-490 - Spleen stiffness measurement: a useful prognostic tool in HCV patients treated with DAAs regimens 170
Nerve fiber overgrowth in patients with symptomatic diverticular disease 169
Non-invasive tests for the prediction of post-hepatectomy liver failure in the elderly 169
Spleen stiffness mirrors changes in portal hypertension after successful interferon-free therapy in chronic-hepatitis C virus patients 168
Role of imaging techniques in liver veno-occlusive disease diagnosis: recent advances and literature review 168
The Role of Microbiota in Upper Gastrointestinal Cancers 167
The Role of the FODMAP Diet in IBS 167
Functional Abdominal Bloating and Gut Microbiota: An Update 166
Nutritional Management in Chronic Pancreatitis: From Exocrine Pancreatic Insufficiency to Precision Therapy 166
Pathophysiology and Therapeutic Strategies for Symptomatic Uncomplicated Diverticular Disease of the Colon 166
Gut Microbiota Characterization in Fecal Incontinence and Irritable Bowel Syndrome 165
Spleen stiffness measurement can predict clinical complications in compensated HCV-related cirrhosis: a prospective study 165
A novel spleen-dedicated stiffness measurement by FibroScan® improves the screening of high-risk oesophageal varices 165
Pancreatic ultrasound elastography is not useful to predict the risk of pancreatic fistulas after pancreatic resection 164
Comparison of prognostic models in predicting survival of patients with advanced hepatocellular carcinoma undergoing sorafenib treatment: a multicenter cohort study 164
Porto-sinusoidal vascular disorder in surgical candidates for liver metastases: prevalence, non-invasive diagnosis, and burden on surgical outcomes 164
Endoscopic Ultrasound-Guided Pancreatic Cystic Fluid Biochemical and Genetic Analysis for the Differentiation Between Mucinous and Non-Mucinous Pancreatic Cystic Lesions 163
Spleen Stiffness Measurements Predict the Risk of Hepatic Decompensation after Direct-Acting Antivirals in HCV Cirrhotic Patients 163
Aortic thrombosis recurrence in a Crohn's disease patient 162
Pathophysiology and Clinical Management of Bile Acid Diarrhea 161
Non-invasive diagnostic approach to non-alcoholic fatty liver disease: Current evidence and future perspectives 160
Prognostic role of nutritional status in elderly patients hospitalized for COVID-19 160
Gastric cancer staging: Is it time for magnetic resonance imaging? 158
Current and Novel Therapies for Eosinophilic Gastrointestinal Diseases 156
Sarcopenia predict complications after hepatic resection for primary hepatocellular carcinoma (HCC) in patients with advanced chronic liver disease (ACLD) and clinically significant portal hypertension (CSPH) 153
Chronic constipation: from pathophysiology to management 153
Gut microbiota and metabolic syndrome. 153
The Gastropack Access System as a Model to Access Gastroenterology Services for Gastroscopy Appropriateness in Patients with Upper Gastrointestinal Symptoms: A Comparison with the Open Access System 152
Approaches to the Diagnosis of Portal Hypertension: Non-Invasive or Invasive Tests? 152
Prognostic factors for hepatocellular carcinoma recurrence 151
Blumgart Anastomosis After Pancreaticoduodenectomy. A Comprehensive Systematic Review, Meta-Analysis, and Meta-Regression 151
Meta-analysis: Post-COVID-19 functional dyspepsia and irritable bowel syndrome 150
Totale 21.296
Salva come PNG Salva come JPEG
Categoria #
all - tutte 100.443
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.443
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021472 0 0 0 0 0 0 0 0 0 0 0 472
2021/20223.133 131 62 95 126 293 124 121 177 184 178 1.230 412
2022/20233.297 272 446 153 391 240 279 149 190 593 94 286 204
2023/20241.784 90 211 121 135 156 348 73 125 107 157 142 119
2024/20256.604 305 736 584 500 797 354 524 315 213 636 589 1.051
2025/202616.622 1.258 1.483 1.395 1.201 1.370 755 2.393 724 2.913 1.237 1.017 876
Totale 35.387